SCHEMBL26523348

SCHEMBL26523348

CC(=O)c1cccc2nc(O)c(O)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
MAPT P10636 4/20 0.41
KMT2A Q03164 3/20 0.41
GAA P10253 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
ACHE P22303 1/20 0.41
NPSR1 Q6W5P4 2/20 0.37
RAB9A P51151 1/20 0.37
RAD52 P43351 2/20 0.36
SMARCA2 P51531 1/20 0.36
THRB P10828 2/20 0.36
HTT P42858 2/20 0.36
POLB P06746 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10555620 0.83 ALDH1A1 (0.70) ALDH1A1MAPTKDM4EACHERAB9A
SCHEMBL94267 0.83 ALDH1A1 (0.70) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL19971558 0.81 ALDH1A1 (0.73) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL29001083 0.81 PARP1 (0.51) ALDH1A1MAPTKDM4EPARP1
SCHEMBL30380155 0.81 PARP1 (0.51) ALDH1A1MAPTKDM4EPARP1
SCHEMBL24186161 0.81 KDM4E (0.62) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL31598603 0.79 ALDH1A1 (0.50) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL10332485 0.77 ALDH1A1 (0.46) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL26523323 0.77 PARP1 (0.43) ALDH1A1MAPTKMT2AGAACYP1A2
SCHEMBL26523318 0.77 PARP1 (0.43) ALDH1A1MAPTKMT2AGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322721-A1 TRIAZOLE DERIVATIVES AND THEIR USE AS TANKYRASE INHIBITORS UNIVERSITY OF OULU (FI) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322721-A1 TRIAZOLE DERIVATIVES AND THEIR USE AS TANKYRASE INHIBITORS CBR3, GBA3, TECR ALDH1A1 2476/4885MAPT 3413/4885KMT2A 4173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.